Lineage Cell Therapeutics, Inc. · AMEX:LCTX
Mulroy Michael H. bought 30,000 Lineage Cell Therapeutics, Inc. shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Mulroy Michael H. (Director) bought 30,000 Lineage Cell Therapeutics, Inc. shares at US$0.87 for US$26,100, leaving 328,555 shares. Filed Nov 19, 2026 (Form 4).
- Bought
- 30,000 shares
- Price
- US$0.87
- Value
- US$26,100
- Holding after
- 328,555 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common Shares | Buy | 30,000 | US$0.87 | 328,555 | Direct |
Source
Download original · View original at SEC
Related
- Lineage Cell Therapeutics, Inc.
- Mulroy Michael H.
- Lineage Cell Therapeutics, Inc. shareholders
- Form 4 · Broadwood Partners, L.P. · Nov 19, 2026
- Form 4 · Andrews Deborah J · Nov 17, 2026
- Form 4 · Culley Brian M · Nov 17, 2026
- Form 4 · Howe Jill Ann · Nov 16, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026